Shein Scales Back Vietnam Operations as US Trade Rules Shift 
SoftBank Q1 Profit Beats Forecast as Intel Rally and OpenAI Investments Boost Returns 
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings 
Mercedes-Benz Stock Offers Deep-Value Potential as Citi Sees Recovery Catalysts 
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop 
DeepSeek to Raise AI API Prices as Demand for New Models Surges 
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised 
OpenAI Restricts Astra AI Over Cyberattack Risks 
Sinopec Boosts Russian ESPO Oil Purchases as Middle East Supply Tightens 
Western Digital Q4 Earnings Beat Estimates as FY2027 Outlook Tops Expectations 
Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations 
Airbnb Stock Jumps After Q2 Earnings Beat, Strong 2026 Outlook 
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users 
Meta Ordered to Pay $567M Over Child Safety Violations in New Mexico 
Nvidia Seen Beating Q2 Targets as Vera Rubin Cycle Begins 
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations 
Glencore Posts Strong H1 2026 Earnings, Announces ASX Secondary Listing 
The current state of the medical cannabis and cannabinoids use…
Achievements, Priorities, Trends, and Barriers
Toronto, Ontario, Feb. 26, 2018 -- The International Pharmaceutical Academy is pleased to announce its third upcoming Medicinal Cannabis Conference being held in Toronto, Canada at DoubleTree by Hilton Toronto Downtown on March 23 - 24, 2018.
This two-day conference will feature 10 of the world renowned experts from across North America including; Dr. Steven Laviolette from Schulich School of Medicine, Dr. Jahan Marcu from Americans for Safe Access Patient Focused Certification program, Dr. Philippe Lucas from The Canadian Medical Cannabis Council, Dr. Mark Lewis from NaPro Research, USA, Dr. Youbin Zheng, University of Guelph, and many more.
This conference will bring together a diverse range of professionals from wide range of research and development, medical, and cannabis industry experts who are directly involved; in Innovations in Cultivation, Processing, Cannabis Extraction, and Product Development of high quality and safe cannabis.
Among other topics, this event will create a forum to share results from ongoing efforts in understanding the use of cannabis (marijuana) for medical purposes in patients, cannabis substitution for opioids, alcohol, tobacco and other substances, and the current position by medical organizations on medical marijuana.
More information about the conference, including registration details, is
available at: http://www.ipacanada.com/CMH2018/index.html
Source: International Pharmaceutical Academy (IPA)
For further information: Media Contact: Rebecca Tan, Communications Co-ordinator, Direct line: (416) 410-7402, Fax: 1-888-236-5480, [email protected]
